Fewer benign biopsies necessary with DBT compared with full-field digital mammography.
Interventions to reduce some traditional risk factors can improve the proportion of non-AIDS-related comorbidities.
From scientific studies to niche-market magazines, supplements are in the spotlight.
Delays observed in first breast imaging, biopsy, incident early-stage breast cancer diagnosis, chemo.
The proportion of human papillomavirus (HPV) 16/18-positive cervical intraepithelial neoplasia grades 2 to 3 or adenocarcinoma in situ (CIN2+) declined from 2008 to 2014.
In the absence of further intervention, in the next 50 years, an estimated 44.4 million women will be diagnosed with cervical cancer globally.
One-third of primary care providers (PCPs) report participating in breast cancer treatment decisions.
In high-risk ambulatory patients with cancer, the incidence of venous thromboembolism or death due to venous thromboembolism during 180 days is not significantly reduced for rivaroxaban compared with placebo.
The US Food and Drug Administration took steps Thursday to tighten regulation of over-the-counter sunscreen products.
The US Preventive Services Task Force (USPSTF) recommends screening for women at increased risk for carrying a BRCA1/2 mutation as well as genetic counseling and testing as indicated for those screening positive.
Radiomic Prognostic Vector IDs patients with median overall survival of less than 2 years.
For children with acute lymphoblastic leukemia (ALL), obesity is associated with an increased risk for adverse events during premaintenance chemotherapy.
Slightly but not significantly increased risks seen in children conceived by ICSI or cryopreservation.
Incidence up for 6 of 12 obesity-related cancers; steeper increase in successively younger generations.
Postmenopausal women with persistent night sweats and/or hot flashes are more likely to be diagnosed with breast cancer compared with women without these vasomotor symptoms.
Physical activity was found to be associated with a reduced risk for hepatocellular carcinoma.
Nonadherence to protocol screenings in a screening trial for multiple cancers may be linked to higher overall mortality, excluding mortality due to cancers studied in the trial.
Worse survival in states with more physicians; higher death rates in states with lower incidence.
The USPSTF recommends risk-reducing medications for women at high risk for breast cancer who are at low risk for adverse events, but medications are not recommended for routine use.
Early treatment of both visible AK lesions and nonvisible sun-damaged skin can eliminate the potential for malignant transformation and decrease the burden of cutaneous squamous cell carcinoma.